Skip to main content
Human Brain Mapping logoLink to Human Brain Mapping
. 2016 Mar 3;37(6):2055–2067. doi: 10.1002/hbm.23159

White matter microstructure and impulsivity in methamphetamine dependence with and without a history of psychosis

Anne Uhlmann 1,, Jean‐Paul Fouche 1,2, Katharina Lederer 1, Ernesta M Meintjes 3, Don Wilson 1, Dan J Stein 1
PMCID: PMC6867545  PMID: 26936688

Abstract

Background: Methamphetamine (MA) use may lead to white matter injury and to a range of behavioral problems and psychiatric disorders, including psychosis. The present study sought to assess white matter microstructural impairment as well as impulsive behavior in MA dependence and MA‐associated psychosis (MAP). Methods: Thirty patients with a history of MAP, 39 participants with MA dependence and 40 healthy controls underwent diffusion tensor imaging (DTI). Participants also completed the UPPS‐P impulsive behavior questionnaire. We applied tract‐based spatial statistics (TBSS) to investigate group differences in mean diffusivity (MD), fractional anisotropy (FA), axial (λ ) and radial diffusivity (λ ), and their association with impulsivity scores and psychotic symptoms. Results: The MAP group displayed widespread higher MD, λ and λ levels compared to both controls and the MA group, and lower FA in extensive white matter areas relative to controls. MD levels correlated positively with negative psychotic symptoms in MAP. No significant DTI group differences were found between the MA group and controls. Both clinical groups showed high levels of impulsivity, and this dysfunction was associated with DTI measures in frontal white matter tracts. Conclusions: MAP patients show distinct patterns of impaired white matter integrity of global nature relative to controls and the MA group. Future work to investigate the precise nature and timing of alterations in MAP is needed. The results are further suggestive of frontal white matter pathology playing a role in impulsivity in MA dependence and MAP. Hum Brain Mapp 37:2055–2067, 2016. © 2016 Wiley Periodicals, Inc.

Keywords: diffusion tensor imaging, impulsive behavior, psychotic disorders, anisotropy, diffusivity, brain, psychostimulant, TBSS


Abbreviations

DTI

Diffusion tensor imaging

EPI

Echo‐planar imaging

FA

Fractional anisotropy

FWE

Family‐wise error

MA

Methamphetamine

MAP

MA‐associated psychosis

MD

Mean diffusivity

ROI

Region of interest

TBSS

Tract‐based spatial statistics

VOI

Voxel of interest

ROI

Region of interest

INTRODUCTION

Emerging evidence from human and animal research suggests that abuse of the psychostimulant methamphetamine (MA) has severe neurotoxic effects, including white matter damage in the form of axonal degeneration and microglial activation [Barr et al., 2006; Krasnova and Cadet, 2009]. But only recently have brain imaging techniques, especially diffusion tensor imaging (DTI), advanced as non‐invasive tools to assess brain white matter pathology. Research studies using magnetic resonance imaging or spectroscopy have reported a variety of white matter abnormalities in MA dependence, specifically hypertrophy in the temporal and occipital lobes [Thompson et al., 2004] as well as lower levels of neuronal integrity markers and higher levels of glial markers in frontal brain areas [Ernst et al., 2000; Sung et al., 2007]. Additionally, converging evidence points to the involvement of white matter abnormalities in psychiatric disorders, such as MAP [Aoki et al., 2013; Howells et al., 2014], bipolar disorder [Barysheva et al., 2013] and schizophrenia [White et al., 2013].

Moreover, impaired cognitive control processes have been associated with MA abuse, leading to behavioral changes characterized by high levels of impulsiveness, hostility and aggression [Dawe et al., 2009; Plüddemann et al., 2010]. In addition to growing evidence that gray matter abnormalities in fronto‐striatal networks potentially underlie impulsivity and affect regulation in addiction [Goldstein and Volkow, 2011; Moreno‐Lopez et al., 2012; Quirk and Beer, 2006; Schwartz et al., 2010], there are data indicating that white matter pathology contributes to the inability to inhibit impulsive acts [Lim et al., 2008; Moeller, 2005]. In MA abuse, decreased glucose metabolism was found in frontal white matter, which was associated with impairment in frontal executive function [Kim et al., 2005]. Thus, the investigation of white matter integrity is important for a better understanding of the neural basis of impulsivity in MA dependence.

Recently, DTI has enabled the examination of white matter microstructural integrity [Le Bihan et al., 2001] that might not be revealed by conventional brain imaging. DTI is a sensitive imaging technique that quantifies the magnitude and directionality of tissue water mobility, which is highly sensitive to differences in membrane microstructural architecture. Information about brain microstructural white matter organization can be derived from fractional anisotropy (FA), mean diffusivity (MD) as well as axial (λ ) and radial diffusivity (λ ). FA reflects the orientation specificity of water diffusion in white matter. A decrease in FA can refer to white matter damage in relation to fiber tract coherence, fiber diameter, packing density and degree of myelination [Alexander et al., 2007]. MD, in turn, represents the degree of water diffusion regardless of fiber directionality and is calculated as the average of the three tensor eigenvalues. An increase in MD can refer to loss of white matter integrity relating to changes in intercellular space and compactness [Beaulieu, 2002]. Substantial experimental evidence has led to the notion that axial (λ ) and radial diffusivity (λ ) may further increase measurement specificity of pathological structure changes [Hasan and Narayana, 2006; Metwalli et al., 2010]. Λ has been proposed as a marker for myelin content, and higher levels of diffusion perpendicular to the white matter tracts may be indicative of axon demyelination [Herrera et al., 2008; Onu et al., 2011]. Λ reflects diffusion parallel to white matter tracts and has been proposed as a marker of axonal integrity. While animal studies linked lower levels of λ to axonal damage [Aung et al., 2013], human studies associated higher λ to neurodegenerative processes [Metwalli et al., 2010]. Nonetheless, due to the complex fiber architecture and an orientation uncertainty, direction of the measured tensor eigenvalues does not always correspond with the underlying structure, especially in pathological tissue [Wheeler‐Kingshott and Cercignani, 2009]. In addition, interpretation of changes to the diffusion tensor is complicated by its sensitivity to image noise, artifacts and crossing fibers, and hence should be done with care [Alexander et al., 2007].

To date, only a few studies have used DTI in MA dependence, and all of them have employed a voxel or region of interest (VOI, ROI) approach. Primarily, these studies investigated the corpus callosum and reported reduced FA in the genu [Kim et al., 2009; Salo et al., 2009; Tobias et al., 2010], a structure involved in the interhemispheric transfer of information and projection into various frontal brain areas. In addition, white matter abnormalities were detected in frontal brain areas [Chung et al., 2007; Tobias et al., 2010], and the dorsal striatum [Alicata et al., 2009], but not in parietal or occipital areas [Chung et al., 2007]. No study has previously assessed white matter integrity in MAP using DTI. However, data from schizophrenia research indicate widespread white matter abnormalities in the brain, including the brain stem and cerebellum [Kyriakopoulos et al., 2008].

Consistent with the notion of there being cognitive impairment and emotional dysregulation in MA dependence, reported white matter changes have been shown to be associated with problems in cognitive control [Chung et al, 2007; Kim et al., 2009; Salo et al., 2009], addiction severity [Alicata et al., 2009] as well as psychiatric symptoms [Tobias et al., 2010]. But the relationship between impulsive behavior and measures of white matter abnormalities in MA and especially MAP remains less clear.

The present study compared white matter integrity in MA dependence with and without a history of psychosis and healthy controls, using fully automated tract‐based spatial statistics (TBSS) [Smith et al., 2006]. As we expected multi‐regional white matter pathology in the MAP group (based on findings in psychosis research), we chose this whole brain analytic approach, allowing for investigation in entire neural networks and not only in predefined regions of interest. We hypothesized that in both MA‐dependent groups white matter structure would be affected, while greater effects and an association with psychotic symptoms were expected in the MAP group. We further investigated how the three study groups differ in five distinct facets of impulsivity and expected higher levels of impulsivity in MA and MAP that would relate to altered microstructural integrity.

MATERIALS AND METHODS

Participants

One hundred and nine participants, comprising 30 MAP patients, 39 participants with MA dependence and no psychosis (MA group), and 40 healthy controls (CTRL group), took part in this study. All participants were right‐handed and matched for age and gender. Route of MA use was by smoking of the crystals exclusively. The patients were recruited from drug rehabilitation facilities and hospitals in Cape Town. Control participants were recruited from local communities using advertisements, and by word of mouth. Participants' diagnosis of current and past disorders as well as group allocation was made based on a clinical assessment carried out by trained staff of the Department of Psychiatry and Mental Health, University of Cape Town, using the Structured Clinical Interview for DSM‐IV‐TR Axis I Disorders (SCID‐Ι) [First et al., 2002]. Additionally, for MAP patients medical charts were consulted when available. Positive and negative symptoms within the MAP group were rated using the Positive and Negative Syndrome Scale (PANSS) [Kay et al., 1987]. Participants were excluded from the study if they presented with: (1) additional substance dependencies other than methamphetamine and nicotine for the MA and MAP groups, or other than nicotine for the control group; (2) a lifetime and current diagnosis of any psychiatric disorders (other than MA dependence and MAP in the MA and MAP groups, respectively); (3) a history of psychosis prior to MA abuse; (4) a medical or neurological illness or head trauma; (5) a seropositive test for HIV; (6) MRI incompatibilities or known claustrophobia. All participants in the MAP group were diagnosed with substance‐induced psychotic disorder and treated with neuroleptic medication; but treatment longer than twelve weeks at the time of scanning was an additional exclusion criterion for the MAP group. Half of the MAP patients (n = 15) received first‐episode treatment, 12 patients had one previous psychotic episode, two patients had two previous episodes and one patient has been hospitalized three times before. The study was approved by the Faculty of Health Sciences Human Research Ethics Committee of the University of Cape Town and complied with ethical guidelines established by the Declaration of Helsinki [World Medical Association, 2013]. After a detailed description of the study, all participants gave written informed consent. Participation was entirely voluntary and consent could be withdrawn at any time without penalties. On completion of the study, participants were compensated with food vouchers for a local supermarket.

Impulsivity Measure

The UPPS‐P impulsive behavior scale [Cyders et al., 2007] assesses five distinct dimensions of impulsivity: Negative Urgency, Lack of Premeditation, Lack of Perseverance, Sensation Seeking, and Positive Urgency. This 59‐item inventory employs a 4‐point Likert‐type response format (1 = Agree Strongly, 2 = Agree some, 3 = Disagree some, 4 = Disagree strongly). The negative and positive urgency dimensions refer to the tendency to engage in impulsive behaviors under the condition of high negative and high positive affect, respectively. Lack of premeditation refers to non‐planning impulsiveness and assesses one's ability to think through potential consequences of one's actions. Lack of perseverance reflects poorer concentration and increased distraction, usually on boring or difficult tasks. Lastly, sensation seeking measures the tendency to seek excitement and stimulation. Due to time restrictions or follow‐up issues, some data were missing in this study; specifically two MA, three MAP and three CTRL participants did not complete the UPPS‐P.

Statistical Analysis

Statistical analysis of demographic, clinical and questionnaire data was performed using the SPSS 22.0 statistical package (Armonk, NY: IBM Corp). The assumption of normality of each continuous variable was analyzed with the Shapiro‐Wilk test, and all datasets appeared to be non‐normally distributed. Consequently, all group comparisons were done using Kruskal‐Wallis tests and follow‐up Mann‐Whitney tests. Nominal data were compared using chi‐square tests. For all analyses P‐values of < 0.05 (two‐tailed) were considered statistically significant.

To examine the relationship of impulsivity scores with MA use measures (age of onset, duration of use, duration of abstinence) and ROI measures of FA, MD, λ , and λ , Spearman's correlation coefficients were calculated. Participants with missing questionnaire data were omitted from these analyses.

Multiple comparisons were corrected by controlling for family‐wise error (FWE) with the Bonferroni‐Holm procedure, with significance thresholded at P < 0.05.

Diffusion Tensor Imaging

Diffusion tensor images were acquired on a Siemens Magnetom 3‐T Allegra scanner at the Cape Universities Brain Imaging Centre, equipped with a CP single channel head coil. Whole brain images were acquired using a single‐shot echo‐planar imaging (EPI) sequence with isotropic (2 × 2 × 2 mm) voxels. The scanning parameters were as follows: TR = 9500 ms, TE = 88 ms, field of view = 240 mm, slice thickness = 2 mm, slices = 70, distance factor = 0, orientation = transversal. Diffusion was measured along 30 directions. For each slice and gradient direction, two images were acquired: with diffusion weighting (b = 1,000 s/mm2) and a single unweighted volume (b = 0 s/mm2). This sequence with a scan time of 5.33 min was repeated three times. Participants were briefed before the scan to minimize motion and were observed during scanning. If gross motion was noticeable, image acquisition was repeated.

DTI processing was performed using the FSL 5.0.2 (FMRIB Software Library, http://www.fmrib.ox.ac.uk/fsl) [Smith et al., 2004]. After correction for eddy‐current distortions, the three acquisitions were exported to Matlab R2013b. Outlier data points were rejected by calculating the Z‐values of the data distribution and discarding any points more than three standard deviations from the mean. Afterwards the corrected acquisitions were affine registered to create a mean DTI image. The mean image was corrected for head motion and brain extraction was applied. At each voxel a diffusion tensor model was fitted to the data and any outliers were removed. Finally, images of FA as well as MD, λ and λ were derived from the model.

Whole brain voxelwise statistical analysis of all diffusion tensor derived measures was carried out using TBSS [Smith et al., 2006]. First, nonlinear registration was used for spatial normalization of DTI data to the Montreal Neurological Institute (MNI152) space, followed by a visual inspection to ensure registration quality. Next, a mean FA image was created (threshold of 0.2) and thinned to create a mean FA skeleton representing the centers of all tracts, i.e., the most compact whole brain white matter, common to all participants. Each participant's aligned DTI measures were then projected onto this skeleton.

For analysis of group differences among the DTI measures a voxelwise permutation‐based non‐parametric inference was performed using FSL's randomize tool [Winkler et al., 2014]. First, a general linear model (GLM) was set up for analysis of covariance, with age, gender and cannabis use in the last year as nuisance covariates to adjust for their potential confounding influence on DTI measures. The primary analysis of main effect of group and follow‐up direct comparisons of the three study groups (in six pairwise contrasts: CTRL > MA, CTRL > MAP, MA > CTRL, MA > MAP, MAP > CTRL, MAP > MA) were tested with 10,000 random permutations. Results were corrected for multiple comparisons by the threshold‐free cluster enhancement (TFCE) method with FWE correction. The threshold for significance was set at P < 0.05. We consulted the “JHU ICBM‐DTI‐81 White Matter Labels Atlas” [Mori et al., 2008] and the “JHU White Matter Tractography Atlas” [Hua et al., 2008] in FSL to identify the most probable anatomical localization of each cluster showing significant between‐group differences. To achieve a more straightforward visualization of the skeletonized results, we employed the “tbss_fill” script to thicken the results somewhat.

New GLMs were set up to investigate associations with psychotic symptoms (PANSS scores) in the MAP group, and associations with MA use measures in both MA‐dependent groups. Again, age, gender and cannabis use in the last year were entered into the models as covariates of no interest. The voxelwise statistical analysis with FSL's randomize tool remained as described above.

Based on the reviewed literature, the relationship with impulsivity was assessed in a priori defined structures of interest found, at least partially, in frontal areas of the brain. These included the genu and body of the corpus callosum, the anterior corona radiata, cingulum, uncinate fasciculus and the superior longitudinal fasciculus, based on the ICBM‐DTI‐81 white‐matter labels atlas [Mori et al., 2008]. With a customized script, mean FA, MD, λ and λ values were extracted from those regions for further correlational analyses with UPPS‐P subscales.

RESULTS

Demographics and Substance Use

There were no significant differences in age and gender distribution between the three study groups (Table 1). However, the control group had significantly higher levels of education compared to the MA, U = 477.5, P = 0.002 and MAP groups, U = 235.5, P < 0.001. Across both MA‐dependent groups, participants did not differ in MA use variables (i.e., duration and onset of use, and duration of abstinence). However, controls smoked significantly less cigarettes than either the MA group, χ 2(1) = 8.19, P = 0.004, or the MAP group, χ 2(1) = 12.34, P < 0.001. Further, there was a significantly lower methaqualone use in CTRL relative to MA, χ 2(1) = 5.48, P = 0.02, in CTRL relative to MAP, χ 2(1) = 17.4, P < 0.001, and in MA relative to MAP, χ 2(1) = 5.41, P = 0.021.

Table 1.

Demographic, methamphetamine use and clinical details

Demographic measures MA MAP CTRL Test for group difference
n = 39 n = 30 n = 40
male/female, n 28/11 23/7 29/11 χ 2(2) = 0.232, P = 0.926
Age in years, median (range) 26 (18–38) 22.5 (19–41) 25 (18–38) H(2) = 2.41, P = 0.299
Level of education in years, median (range) 10 (8–15) 10 (6–15) 12 (9–14) H(2) = 19.9, P < 0.001
Tobacco smokers in last year, n 33 28 22 χ 2(2) = 16.27, P < 0.001
Alcohol consumers in last year, n 20 9 17 χ 2(2) = 3.15, P = 0.207
Cannabis users in last year, n 10 14 14 χ 2(2) = 3.30, P = 0.192
Methaqualone users in last year, n 5 11 0 χ 2(2) = 18.57, P < 0.001
MA use measures
Age at first use in years, median (range) 17 (12–32) 17 (12–40) U = 504.5, P = 0.327
Duration in years, median (range) 6 (1.5–19) 6.5 (1–18) U = 534.0, P = 0.535
Abstinence in days, median (range) 21 (1–240) 41 (1–270) U = 455.5, P = 0.116
Clinical measures
Neuroleptic medication in days, M ± SD (range) 44.5 ± 19 (14–85)
PANSS negative symptoms, median (range) 9 (7–37)
PANSS positive symptoms, median (range) 10.5 (7–29)
PANSS psychopathology, median (range) 22 (16–46)

PANSS: Positive and negative syndrome scale. M: mean, SD: standard deviation.

Impulsivity Measure

Table 2 summarizes descriptive UPPS‐P scores, group statistic and pairwise comparisons for the MA, MAP and CTRL groups. Both MA‐dependent groups showed higher impulsivity scores than the CTRL group, but no differences were found between the MA and MAP groups. Impulsivity scores showed no significant correlation with MA use variables (in both MA‐dependent groups) or clinical measures (in MAP group) that survived correction for multiple testing.

Table 2.

Mean scores and group comparisons of distinct impulsivity dimensions

Group comparisons
MA MAP CTRL Group Statistic MA—CTRL MAP—CTRL MA—MAP
UPPS‐P dimensions n = 37 n = 27 n = 37 H(2) U P r U P r U P r
Negative urgency 34 (18–44) 33 (18–45) 25 (15–48) 21.27** 315.5 <0.001 0.46 215.0 <0.001 0.48 492.5 0.924 0.01
Lack of premeditation 21 (11–33) 21 (12–35) 19 (11–33) 4.85n.s.
Lack of perseverance 18 (11–30) 21 (13–29) 16 (10–27) 8.96* 515.5 0.067 0.21 279.0 0.003 0.38 420.0 .278 0.14
Sensation seeking 35 (12–48) 35 (27–48) 34 (15–47) 0.707n.s.
Positive urgency 35 (14–53) 38 (22–55) 24 (15–53) 24.74** 350.0 <0.001 0.42 157.5 <0.001 0.58 393.5 0.149 0.18

UPPS‐P scores are displayed in median (range). H: Kruskal –Wallis test statistic, U: Mann‐Whitney test statistic, r: effect size. *P < 0.05, **P < 0.001, n.s.—Non‐significant. Significant results within each subscale survive FWE correction.

TBSS Main Effects and Group Comparisons

Covarying for age, gender and cannabis use in the last year, the GLM revealed a significant main effect of group on all four DTI measures, FA, MD, λ and λ . Corresponding cluster details, including voxel number, peak MNI coordinates, test statistic, effect size and affected white matter tracts, are listed in Table 3. While main effects in MD and λ covered widespread white matter regions (totaling 59,168 and 49,697 voxels, respectively), main effects in FA (total of 1,160 voxels) and λ (1,837 voxels) were more spatially restricted (see Fig. 1). In follow‐up group comparisons, no statistically significant differences were found between the MA and CTRL groups for any DTI measure.

Table 3.

Main effects and group differences in DTI measures

DTI output Voxel number MNI coordinates F or t‐value Effect size r
x y z White matter tracts
FA, main effect 620 −12 −7 −8 10.7 ant. thalamic radiation, cerebral peduncle, corticospinal tract, forceps minor
478 13 −11 −11 17.1 corticospinal tract, cerebral peduncle, post. limb of internal capsule, ant. thalamic radiation
27 16 −18 −2 8.29 corticospinal tract, ant. thalamic radiation
20 22 21 5 10 ant. thalamic radiation, inf. fronto‐occipital fasc., ant. limb of internal capsule
15 8 −15 −18 9.32 cerebral peduncle
CTRL>MAP 46170 −18 −27 53 5.08 0.53 corticospinal tract, ant. thalamic radiation, cingulum, forceps major+minor, inf.+sup. longitudinal fasc., uncinate, cerebellum, CC
26 −26 24 −13 3.07 0.35 uncinate fasc.
MD, main effect 59168 −22 −39 43 23.3 corticospinal tract, sup.+post. corona radiata, cingulum, inf.+sup. longitudinal fasc.
MAP>CTRL 78130 −22 −39 43 6.81 0.64 extensive white matter areas
MAP>MA 78130 −22 −39 43 6.81 0.64 extensive white matter areas
λ, main effect 49697 13 −11 −11 20.3 ant. thalamic radiation, corticospinal tract, cingulum, inf. fronto‐occipital fasc., inf.+sup. long. fasc., uncinate fasc.
231 −5 23 −2 11.2 forceps minor, genu of CC
MAP>CTRL 81117 −19 −28 49 5.65 0.57 extensive white matter areas
MAP>MA 81117 −19 −28 49 5.65 0.57 extensive white matter areas
λ, main effect 1714 14 4 31 10.6 corona radiata, CC, inf.+sup. long. fasc., corticospinal tract, uncinate, forceps major+minor, cingulum, internal+external capsule
87 4 23 15 9.51 forceps minor, genu of CC
36 6 2 25 5.02 body of CC
MAP>CTRL 34817 27 −33 56 4.79 0.50 sup. long. fasc., corticospinal tract, cingulum, forceps major+minor, inf.+sup. long. fasc., uncinate fasc., ant. thalamic radiation
65 −54 −35 10 3.9 0.43 sup. long. fasc.
36 −39 −45 20 3.7 0.41 sup. long. fasc.
MAP>MA 34817 27 −33 56 4.79 0.51 sup. long. fasc., corticospinal tract, cingulum, forceps major+minor, inf.+sup. long. fasc., uncinate fasc., ant. thalamic radiation
241 −39 −45 20 3.7 0.41 sup. long. fasc.
171 −54 −35 10 3.9 0.43 sup. long. fasc.
62 −13 −74 17 4.75 0.50 occipital lobe white matter
14 −21 −88 0 3.47 0.39 forceps major, inf. long. fasc., inf. fronto‐occipital fasc.

Local maximum values/peak coordinates are given in mm. MNI – Montreal Neurological Institute. White matter labels were derived with FSL atlasquery command, consulting the JHU ICBM‐DTI‐81 and the JHU White Matter Tractography Atlas. CC – corpus callosum; ant. ‐ anterior; fasc. ‐ fasciculus; inf. ‐ inferior; post. ‐ posterior, sup. ‐ superior.

Figure 1.

Figure 1

Main effects and group differences in mean diffusivity (MD), axial diffusivity (λ ), radial diffusivity (λ ), and FA, covaried for age, gender and cannabis use in the last year (P < 0.05, corrected for multiple comparisons). Significant clusters (red) are overlaid onto mean white matter skeleton (green) and thickened to enhance visualization. Groups: MA—methamphetamine dependent individuals, MAP—methamphetamine‐associated psychosis patients, CTRL—healthy controls. Slices in MNI coordinates x, y, z in mm: A = −22, −39, 36; B = −22, −39, 36; C = −22, −39, 36; D = 14, 4, 31; E = 27, −33, 31; F = 27, −33, 31; G = 13, −11, −11; H = −19, −28, 0; I = −19, −28, 0; J = −12, −7, −8; K = −18, −27, 26.

MAP versus CTRL

Compared to healthy controls, MAP patients showed significantly lower FA (total of 46,196 voxels) and higher MD (78,130 voxels), λ (34,918 voxels) and λ (81,117 voxels) in widespread areas extending into frontal, temporal, parietal and occipital white matter bilaterally and comprising all major white matter tracts, e.g., the corticospinal tracts, longitudinal fasciculi, fronto‐occipital fasciculi, uncinate fasciculi, thalamic radiations, corpus callosum, cingulum, internal and external capsule, and cerebral peduncle (see Fig. 1 and Table 3).

MAP versus MA

MAP patients exhibited similarly widespread differences in MD (78,130 voxels), λ (35,305 voxels) and λ (81,117 voxels) relative to MA; but no significant group differences were found in FA (see Fig. 1 and Table 3).

TBSS Correlations

MA measures correlations

In the MA group, correlational analyses revealed a positive relationship between λ values and MA abstinence in several clusters (totaling 20,785 voxels; 0.66 ≤ r ≥ 0.73), comprising several major white matter tracts (see Fig. 2A and Table 4).

Figure 2.

Figure 2

Significant positive correlations of mean diffusivity (MD), FA, and radial diffusivity (λ ) with duration of methamphetamine abstinence and negative psychotic symptoms covaried for age, gender and cannabis use in the last year (P < 0.05, corrected for multiple comparisons). Significant clusters (red) are overlaid onto mean white matter skeleton (green) and thickened to enhance visualization. Groups: MA—methamphetamine dependent individuals, MAP—methamphetamine‐associated psychosis patients. Slices in MNI coordinates x, y, z in mm: A = 25, −16, 33; B = 13, 32, 8; C = −16, −15, 32.

Table 4.

DTI correlations with methamphetamine abstinence

Group DTI output Voxel number t value MNI coordinates Effect size r
x y z White matter tracts
MA λ 11908 5.91 25 6 44 0.71 inf.+sup. long. fasc, cingulum (hippocampus), ucinate fasc.
8177 6.31 −25 −31 33 0.73 corticospinal tract, sup. long. fasc., post. corona radiata
654 5.17 −32 −31 41 0.66 sup. long. fasc.
46 5.39 −51 −43 19 0.67 sup. long. fasc.
MAP FA 988 5.62 −4 −30 −19 0.75 ant. thalamic radiation, corticospinal tract, cerebral perduncle, sup. cerebellar peduncle
531 4.72 41 32 8 0.69 ant. thalamic radiation, inf. fronto‐occip fasc., sup. long. fasc, ant. thalmamic radiation, uncinate fasc.
188 3.64 17 −36 28 0.59 splenium of CC
177 3.43 −3 −24 23 0.57 splenium + body of CC
105 4.82 −13 35 0 0.69 forceps minor, cingulum, uncinate fasc., ant. thalamic radiation, genu of CC, ant. corona radiata
48 3.44 −23 31 14 0.57 ant.corona radiata, ant. thalamic radiation, inf. fronto−occip fasc, forceps minor, uncinate fasc.
47 4.66 −25 −52 5 0.68 forceps major, cingulum (hippocampus)
43 4.24 23 18 18 0.65 ant. corona radiata, ant. thalamic radiation, inf. fronto‐occip fasc., forceps minor, uncinate fasc.
17 2.95 −25 30 8 0.51 inf. fronto‐occip fasc., ant. thalamic radiation, uncinate fasc., ant. corona radiata

Local maximum values/peak coordinates are given in mm. MNI – Montreal Neurological Institute. White matter labels were derived with FSL atlasquery command, consulting the JHU ICBM‐DTI‐81 and the JHU White Matter Tractography Atlas. CC – corpus callosum; ant. ‐ anterior; fasc. ‐ fasciculus; inf. ‐ inferior; post. ‐ posterior, sup. ‐ superior.

In the MAP group, FA values correlated positively with MA abstinence in several clusters (totaling 2,144 voxels; 0.51 ≤ r ≥ 0.75), including frontal, cerebellar and subcortical white matter (see Fig. 2B and Table 4).

No statistically significant relationships were detected between DTI measures and MA onset or duration.

Psychotic symptoms correlations

In the MAP group, we detected a significant relationship between higher scores on the PANSS negative symptoms subscale and MD values (peak MNI x, y, z: −16, −15, 34; tmax = 6.98; r = 0.81; voxels = 19,030), which covered areas of the corpus callosum, thalamic radiations, corona radiata, longitudinal fasciculi, fronto‐occipital fasciculi, cingulum, corticospinal tract, uncinate fasciculus, internal capsule and cerebral peduncle (Fig. 2C).

No statistically significant relationships were detected between DTI measures and scores of the PANSS positive symptom and general psychopathology scales, or duration of neuroleptic treatment.

ROI Impulsivity Correlation

To examine the relationship of the three impulsivity subscales, that showed significant between‐group differences, with FA, MD, λ and λ values in the pre‐selected regions of interest, Spearman correlation analyses were done. After FWE correction, a significant positive correlation between left uncinate fasciculus FA and negative urgency scores (rs = 0.45, P = 0.005) was found in the MA group. In the MAP group, MD and λ in the right anterior corona radiata correlated with negative urgency scores (rs = 0.65, P < 0.001; rs = 0.55, P = 0.003, respectively) as well as positive urgency scores (rs = 0.66, P < 0.001; rs = 0.63, P < 0.001, respectively). In the control group, positive urgency scores correlated with FA in the right uncinate fasciculus (rs = 0.46, P = 0.005) and λ in the left superior longitudinal fasciculus (rs = 0.47, P = 0.004).

DISCUSSION

This DTI investigation of whole brain white matter integrity and its association with impulsivity revealed three main findings in MA and MAP. First, patients with MAP demonstrated globally diminished white matter integrity as evidenced by lower FA compared to CTRLs and higher MD, λ and λ values relative to both the CTRL and MA groups. Second, greater MD values correlated significantly with negative psychotic symptoms. Third, both MA‐dependent study groups showed high levels of self‐report impulsivity, which were significantly associated with regional frontal white matter integrity measures. On a cautionary note, one must acknowledge that brain imaging results in psychiatric diseases, especially their linkage to signs and symptoms of the various disorders, require a speculative interpretation. However, DTI imaging has been widely applied in clinical examination and research in psychiatric disorders, and there is emerging evidence of generalized white matter and myelination abnormalities either distinct or shared across disorders [Fields, 2008; Shizukuishi et al., 2013; White et al., 2008].

In MAP patients, white matter microstructure changes were found to be widespread. In keeping with our hypothesis, the MAP group showed extensive high levels of MD, λ and λ compared to the MA group and controls, together with low FA values compared to controls. High MD levels are likely related to increases in the spacing between membrane layers or increases in water content due to tissue inflammation or myelin loss in the brain [Alexander et al., 2007; Beaulieu, 2002]. The widespread high levels of λ (comprising even more voxels than MD) support the notion of axon demyelination in MAP. The additional observation (in less widespread areas and fewer voxels) of low FA and high λ values may indicate injury to the axonal fiber, although it has been shown that λ may also be influenced by myelin integrity and intraaxonal composition [Harsan et al., 2006]. While no study has examined white matter microstructure in MAP before, many DTI studies in schizophrenia have found low FA and high MD in fiber bundles across the frontal, temporal, parietal, and occipital lobes [Kubicki et al., 2007; Kyriakopoulos et al., 2008]. This suggests a general disorganization of axon fiber architecture rather than a focal damage. Similarly, DTI measure changes reported in the present study highlight a possible interruption of diffusion along axon fibers in widespread areas of the brain in patients with MAP. In any case, efficient communication between brain circuits depends on myelination of axons to facilitate fast saltatory signal transmission. In schizophrenia research, there is growing evidence pointing to widespread changes in the cells responsible for myelination, oligodendrocytes; and degenerative changes in myelinated fibers have previously been implicated in the pathophysiology [Takahashi et al., 2011]. There is also evidence for MA‐induced cytotoxicity in oligodendrocytes leading to cell death [Genc et al., 2003], which may exacerbate the effects of additional susceptibility factors for white matter damage and the development of psychosis in some MA‐dependent individuals. Supportive of this notion is the observation in the present study that FA values improve with ongoing abstinence from the drug.

Against our initial hypothesis, and despite proposed inflammatory processes and associated microgliosis in striatal and frontal brain areas in MA [Asanuma et al., 2004; Schwartz et al., 2010; Thompson et al., 2004], we did not detect differences in DTI measures in the MA group, compared to healthy controls. Previous reports of changes in frontal, striatal and corpus callosum white matter integrity in MA assessed DTI measures in small VOIs or ROIs exclusively [Chung et al., 2007; Kim et al., 2009; Salo et al., 2009; Tobias et al., 2010]. One potential explanation for the lack of replication of these findings in the present study may be the lower statistical power in whole brain analyses, as greater areas and higher voxel numbers are assessed, leading to an increase in comparisons that need to be controlled for. Also, though previous research studies in MA addiction excluded participants with current or past dependences on other drugs, it is not clear if use of other drugs, especially cannabis has been considered and if statistical models were adjusted for this important potential confounder [Becker et al., 2015].

In the present study, negative psychotic symptoms correlated with MD in widespread white matter areas in MAP. This result, in addition to the finding of degraded white matter in extensive brain areas, may provide new evidence for the involvement of disrupted white matter integrity in the pathology of MAP. In schizophrenia, degraded white matter near the right insula has been shown to correlate with the PANSS negative symptoms subscore [Shin et al., 2006]. The observed disruptions in white matter integrity, potentially representing white matter swelling and demyelination, may underlie the impaired integration of information in MAP. The issue whether these white matter effects are a direct cause or a consequence of the psychotic disorder, however, cannot be disentangled with this study design.

Still, these findings support the notion that diminished white matter connectivity may affect symptoms in psychotic disorders [Fields 2008]. Therefore, DTI seems a useful tool to monitor the progress of psychopathology [Lagopoulos et al., 2013] or recovery and response to treatment longitudinally and should be used as a routine clinical protocol. Such assessment of cerebral white matter for anatomic disconnectivity may further instigate early treatment as myelin disruptions are evident in the earliest stages in individuals at high risk for psychosis [Karlsgodt et al., 2009; Carletti et al., 2012; Lagopoulos et al., 2013].

When assessing impulsivity, scores on the negative and positive urgency subscales of the UPPS‐P were significantly higher for the two MA‐dependent groups, compared to CTRLs. Therefore, in MA dependence with and without a history of psychosis heightened negative or positive affect may lead to inhibition difficulties. This finding is in keeping with recent studies showing that urgency was most strongly associated with substance use problems and dependence [Verdejo‐Garcia et al., 2007; Stautz and Cooper, 2013]. The amplified tendency to give in to strong impulses may stem from poor emotion regulation and result in limited ways of responding, as seen in the high relapse rates in MA. In this light, interventions focusing on emotion regulation strategies to decrease urgency may achieve greater favorable preventive effects. Our finding of heightened impulsivity levels is in line with previous reports in MA abuse [Kim et al., 2005; Semple et al., 2005]. However, in the present study, impulsivity scores were not associated with MA use onset, duration or abstinence or with psychotic symptoms, suggesting that impulsivity may represent a trait marker in MA abusers.

We further tested if disconnected frontal white matter might be associated with high levels of impulsivity and found significant correlations of impulsivity dimensions with white matter integrity (higher diffusivity measures) in the right corona radiata in MAP and left superior longitudinal fasciculus in CTRLs. This is in support of our initial hypothesis and also in keeping with previous findings of impaired white matter integrity in frontal brain areas, amongst others, relating to impulsivity measures in schizophrenia and stimulant addiction [Hoptman et al., 2004; Moeller, 2005]. However, our findings in the MA and CTRL groups of higher FA in the uncinate fasciculus correlating with higher levels of impulsivity are counterintuitive, and may not reflect changes in microstructural architecture relating to behavioral changes.

Several cautionary notes should be pointed out regarding this study. First, all MAP patients were on neuroleptic treatment, which may have impacted the results. As cell culture studies have highlighted multiple potential effects of typical antipsychotics, including neuronal apoptosis induction [Noh et al., 2000], non‐suppression of oligodendrocytes apoptosis [Seki et al., 2013], but also anti‐inflammatory cytokines increase [Al‐Amin et al., 2013], imaging studies have not provided coherent results of neuroleptic effects on brain structure yet. Some DTI studies reported a correlation of antipsychotic medication and reduced FA in frontal lobe areas [Minami et al., 2003; Wang et al., 2013], while other studies in schizophrenia did not observe an effect on white matter microstructure [Kyriakopoulos et al., 2008]. Similarly, in our study we found no evidence for a relationship between medication duration and DTI measures. However, only half of our study patients were diagnosed with first‐episode MAP, while the other half has experienced at least one episode before study enrollment. In the latter group, non‐compliance or partial compliance to medical treatment has been identified with common occurrence. Nonetheless, a potential effect of those previous treatments on reported DTI measures cannot be fully ruled out. Second, exact fiber tract identification in clusters that emerged from the different analyses is still difficult in areas where different tracts run together or cross. Also a definite interpretation of changes in the tensor‐derived measures in terms of underlying microstructural white matter injury, including demyelination, degradation of membranes, and axonal loss, is not yet possible. Third, the present study included only a self‐report measure of impulsivity and reliability of given answers may be questionable at times. The inclusion of behavioral measures of impulsivity might have helped to validate the results. Fourth, there was a significant difference in tobacco and methaqualone smoking between controls and the two MA‐dependent groups, representing a potential confounding factor to our results. As for white matter abnormalities associated with cigarette smoking, previous studies reported inconsistent results, while opposing effects may be possible in heavy and light smokers [Gons et al., 2011; Liao et al., 2011; Paul et al., 2008; Savjani et al., 2014]. However, in schizophrenia research it has been shown that both disease and smoking status do not only have independent but also additive effects on white matter integrity, specifically on FA levels in the anterior thalamic radiation and anterior limb of the internal capsule [Zhang et al., 2010]. Finally, the cross‐sectional nature of our data does not permit us to make any causal statement regarding the relationship between MA use and impulsivity. It might well be that individuals who have a predisposition to elevated levels of impulsivity are more likely to engage in drug use. Alternatively, long‐term use of MA may result in elevated levels of impulsivity due to its neurotoxic effects on the brain. Longitudinal data and prospective research designs are needed to address this issue of causality as well as the issue of developing white matter changes as addiction and related psychopathology progress.

In summary, the use of an automated voxelwise whole brain method for analysis of DTI data has provided new information on how white matter is affected in MAP. The present study demonstrated significantly higher levels of mean, axial and radial diffusivity together with low FA levels in MAP, representing globally impaired white matter integrity similar to that seen in schizophrenia. Further, indices of disordered neuronal architecture were associated with psychotic symptoms in broad white matter areas. In both MA‐dependent groups with and without a history of psychosis, frontal white matter pathology related to reported high levels of impulsive behavior.

ACKNOWLEDGMENTS

A.U. wishes to thank the University of Cape Town for scholarships during the time in which this project was conducted.

Dr. Stein reports having received research grants and/or consultancy honoraria from Abbott, ABMRF, Astrazeneca, Biocodex, Eli‐Lilly, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, Lundbeck, National Responsible Gambling Foundation, Novartis, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, Sun, Takeda, Tikvah, and Wyeth.

REFERENCES

  1. Al‐Amin MM, Nasir Uddin MM, Mahmud Reza H (2013): Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin Psychopharmacol Neurosci 11:144–151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alexander AL, Lee JE, Lazar M, Field AS (2007): Diffusion tensor imaging of the brain. Neurotherapeutics 4:316–329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alicata D, Chang L, Cloak C, Abe K, Ernst T (2009): Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users. Psychiatry Res 174:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aoki Y, Orikabe L, Takayanagi Y, Yahata N, Mozue Y, Sudo Y, Ishii T, Itokawa M (2013): Volume reductions in frontopolar and left perisylvian cortices in methamphetamine induced psychosis. Schizophr Res 147:355–361. [DOI] [PubMed] [Google Scholar]
  5. Asanuma M, Miyazaki I, Higashi Y, Tsuji T, Ogawa N (2004): Specific gene expression and possible involvement of inflammation in methamphetamine‐induced neurotoxicity. Ann NY Acad Sci 1025:69–75. [DOI] [PubMed] [Google Scholar]
  6. Aung WY, Mar S, Benzinger TL (2013): Diffusion tensor MRI as a biomarker in axonal and myelin damage. Imaging in Medicine 5:427–440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T (2006): The need for speed: An update on methamphetamine addiction. J Psychiatr Neurosci 31:301–313. [PMC free article] [PubMed] [Google Scholar]
  8. Becker MP, Collins PF, Lim KO, Muetzel RL, Luciana M (2015): Longitudinal changes in white matter microstructure after heavy cannabis use. Dev Cogn Neurosci 16:23–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Barysheva M, Jahanshad N, Foland‐Ross L, Altshuler LL, Thompson PM (2013): White matter microstructural abnormalities in bipolar disorder: A whole brain diffusion tensor imaging study. NeuroImage Clin 2:558–568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Beaulieu C (2002): The basis of anisotropic water diffusion in the nervous system—A technical review. NMR Biomed 15:435–455. [DOI] [PubMed] [Google Scholar]
  11. Carletti F, Woolley JB, Bhattacharyya S, Perez‐Iglesias R, Poli PF, Valmaggia L, Broome MR, Bramon E, Johns L, Giampietro V, Williams SCR, Barker GJ, McGuire PK (2012): Alterations in white matter evident before the onset of psychosis. Schizophr Bull 38:1170–1179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chung A, Lyoo IK, Kim SJ, Hwang J, Bae SC, Sung YH, Sim ME, Song IC, Kim J, Chang KH, Renshaw PF (2007): Decreased frontal white‐matter integrity in abstinent methamphetamine abusers. Int J Neuropsychopharmacol 10:765–775. [DOI] [PubMed] [Google Scholar]
  13. Cyders MA, Smith GT, Spillane NS, Fischer S, Annus AM, Peterson C (2007): Integration of impulsivity and positive mood to predict risky behavior: Development and validation of a measure of positive urgency. Psychol Assess 19:107–118. [DOI] [PubMed] [Google Scholar]
  14. Dawe S, Davis P, Lapworth K, McKetin R (2009): Mechanisms underlying aggressive and hostile behavior in amphetamine users. Curr Opin Psychiatry 22:269–273. [DOI] [PubMed] [Google Scholar]
  15. Ernst T, Chang L, Leonido‐Yee M, Speck O (2000): Evidence for long‐term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology 54:1344–1349. [DOI] [PubMed] [Google Scholar]
  16. Fields RD (2008): White matter in learning, cognition and psychiatric disorders. Trends Neurosci 31:361–370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. First MB, Gibbon M, Spitzer RL, Williams JBW (2002): User's Guide for the Structured Clinical Interview for DSM‐IV‐TR Axis I Disorders—Research Version ‐ (SCID‐I for DSM‐IV‐TR, November 2002 Revision).
  18. Genc K, Genc S, Kizildag S, Sonmez U, Yilmaz O, Tugyan K, Ergur B, Sonmez A, Buldan Z (2003): Methamphetamine induces oligodendroglial cell death in vitro. Brain Res 982:125–130. [DOI] [PubMed] [Google Scholar]
  19. Goldstein RZ, Volkow ND (2011): Dysfunction of the prefrontal cortex in addiction: Neuroimaging findings and clinical implications. Nat Rev Neurosci 12:652–669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gons RA, van Norden AG, de Laat KF, van Oudheusden LJ, van Uden IW, Zwiers MP, Norris DG, de Leeuw FE (2011): Cigarette smoking is associated with reduced microstructural integrity of cerebral white matter. Brain 134:2116–2124. [DOI] [PubMed] [Google Scholar]
  21. Harsan LA, Poulet P, Guignard B, Steibel J, Parizel N, de Sousa PL, Boehm N, Grucker D, Ghandour MS (2006): Brain dysmyelination and recovery assessment by noninvasive in vivo diffusion tensor magnetic resonance imaging. J Neurosci Res 83:392–402. [DOI] [PubMed] [Google Scholar]
  22. Hasan KM, Narayana PA (2006): Retrospective measurement of the diffusion tensor eigenvalues from diffusion anisotropy and mean diffusivity in DTI. Magn Reson Med 56:130–137. [DOI] [PubMed] [Google Scholar]
  23. Herrera JJ, Chacko T, Narayana PA (2008): Histological correlation of diffusion tensor imaging metrics in experimental spinal cord injury. J Neurosci Res 86:443–447. [DOI] [PubMed] [Google Scholar]
  24. Hoptman MJ, Ardekani BA, Butler PD, Nierenberg J, Javitt DC, Lim KO (2004): DTI and impulsivity in schizophrenia: A first voxelwise correlational analysis. Neuroreport 15:2467–2470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Howells FM, Uhlmann A, Temmingh H, Sinclair H, Meintjes EM, Wilson D, Stein DJ (2014): 1H‐MRS in methamphetamine dependence and methamphetamine induced psychosis. Schizophr Res 153:122–128. [DOI] [PubMed] [Google Scholar]
  26. Hua K, Zhang J, Wakana S, Jiang H, Li X, Reich DS, Calabresi PA, Pekar JJ, van Zijl PC, Mori S (2008): Tract probability maps in stereotaxic spaces: Analyses of white matter anatomy and tract‐specific quantification. NeuroImage 39:336–347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Karlsgodt KH, Niendam TA, Bearden CE, Cannon TD (2009): White matter integrity and prediction of social and role functioning in subjects at ultra‐high risk for psychosis. Biol Psychiatry 66:562–569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kay SR, Fiszbein A, Opler LA (1987): The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276. [DOI] [PubMed] [Google Scholar]
  29. Kim IS, Kim YT, Song HJ, Lee JJ, Kwon DH, Lee HJ, Kim MN, Yoo DS, Chang Y (2009): Reduced corpus callosum white matter microstructural integrity revealed by diffusion tensor eigenvalues in abstinent methamphetamine addicts. Neurotoxicology 30:209–213. [DOI] [PubMed] [Google Scholar]
  30. Kim SJ, Lyoo IK, Hwang J, Sung YH, Lee HY, Lee DS, Jeong DU, Renshaw PF (2005): Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology 30:1383–1391. [DOI] [PubMed] [Google Scholar]
  31. Krasnova IN, Cadet JL (2009): Methamphetamine toxicity and messengers of death. Brain Res Rev 60:379–407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kubicki M, McCarley R, Westin CF, Park HJ, Maier S, Kikinis R, Jolesz FA, Shenton ME (2007): A review of diffusion tensor imaging studies in schizophrenia. J Psychiatry Res 41:15–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kyriakopoulos M, Bargiotas T, Barker G, Frangou S (2008): Diffusion tensor imaging in schizophrenia. Eur Psychiatry 23:255–273. [DOI] [PubMed] [Google Scholar]
  34. Lagopoulos J, Hermens DF, Hatton SN, Battisti RA, Tobias‐Webb J, White D, Naismith SL, Scott EM, Ryder WJ, Bennett MR, Hickie IB (2013): Microstructural white matter changes are correlated with the stage of psychiatric illness. Transl Psychiatry 3:e248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H (2001): Diffusion tensor imaging: Concepts and applications. J Magn Reson Imaging 13:534–546. [DOI] [PubMed] [Google Scholar]
  36. Liao Y, Tang J, Deng Q, Deng Y, Luo T, Wang X, Chen H, Liu T, Chen X, Brody AL, Hao W (2011): Bilateral fronto‐parietal integrity in young chronic cigarette smokers: A diffusion tensor imaging study. PLoS ONE 6:e26460 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Lim KO, Wozniak JR, Mueller BA, Franc DT, Specker SM, Rodriguez CP, Silverman AB, Rotrosen JP (2008): Brain macrostructural and microstructural abnormalities in cocaine dependence. Drug Alcohol Depend 92:164–172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Metwalli NS, Benatar M, Nair G, Usher S, Hu X, Carew JD (2010): Utility of axial and radial diffusivity from diffusion tensor MRI as markers of neurodegeneration in amyotrophic lateral sclerosis. Brain Res 1348:156–164. [DOI] [PubMed] [Google Scholar]
  39. Minami T, Nobuhara K, Okugawa G, Takase K, Yoshida T, Sawada S, Ha‐Kawa S, Ikeda K, Kinoshita T (2003): Diffusion tensor magnetic resonance imaging of disruption of regional white matter in schizophrenia. Neuropsychobiology 47:141–145. [DOI] [PubMed] [Google Scholar]
  40. Moeller (2005): Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine‐dependent subjects: Diffusion tensor imaging. Neuropsychopharmacology 30:610–617. [DOI] [PubMed] [Google Scholar]
  41. Moreno‐Lopez L, Catena A, Fernandez‐Serrano MJ, Delgado‐Rico E, Stamatakis EA, Perez‐Garcia M, Verdejo‐García A (2012): Trait impulsivity and prefrontal gray matter reductions in cocaine dependent individuals. Drug Alcohol Depend 125:208–214. [DOI] [PubMed] [Google Scholar]
  42. Mori S, Oishi K, Jiang H, Jiang L, Li X, Akhter K, Hua K, Faria AV, Mahmood A, Woods R, Toga AW, Pike GB, Neto PR, Evans A, Zhang J, Huang H, Miller MI, van Zijl P, Mazziotta J (2008): Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. NeuroImage 40:570–582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Noh JS, Kang HJ, Kim EY, Sohn S, Chung YK, Kim SU, Gwag BJ (2000): Haloperidol‐induced neuronal apoptosis: Role of p38 and c‐Jun‐NH(2)‐terminal protein kinase. J Neurochem 75:2327–2334. [DOI] [PubMed] [Google Scholar]
  44. Onu M, Ferastraoaru V, Roceanu A, Bajenaru A (2011): Axial diffusivity—An intriguing MR marker. Eur Soc Radiol Poster C‐1499. [Google Scholar]
  45. Paul RH, Grieve SM, Niaura R, David SP, Laidlaw DH, Cohen R, Sweet L, Taylor G, Clark CR, Pogun S, Gordon E (2008): Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: A diffusion tensor imaging study. Nicotine Tob Res 10:137–147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Plüddemann A, Flisher AJ, Mathews C, Parry CDH, Lombard CA (2010): Methamphetamine use, aggressive behaviour and other mental health issues among high‐school students in Cape Town, South Africa. Drug Alcohol Depend 109:14–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Quirk GJ, Beer JS (2006): Prefrontal involvement in the regulation of emotion: Convergence of rat and human studies. Curr Opin Neurobiol 16:723–727. [DOI] [PubMed] [Google Scholar]
  48. Salo R, Nordahl TE, Buonocore MH, Natsuaki Y, Waters C, Moore CD, Galloway GP, Leamon MH (2009): Cognitive control and white matter callosal microstructure in methamphetamine‐dependent subjects: A diffusion tensor imaging study. Biol Psychiatry 65:122–128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Savjani RR, Velasquez KM, Thompson‐Lake DG, Baldwin PR, Eagleman DM, De La Garza R, 2nd Salas R (2014): Characterizing white matter changes in cigarette smokers via diffusion tensor imaging. Drug Alcohol Depend 145:134–142. [DOI] [PubMed] [Google Scholar]
  50. Schwartz DL, Mitchell AD, Lahna DL, Luber HS, Huckans MS, Mitchell SH, Hoffman WF (2010): Global and local morphometric differences in recently abstinent methamphetamine‐dependent individuals. NeuroImage 50:1392–1401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Seki Y, Kato TA, Monji A, Mizoguchi Y, Horikawa H, Sato‐Kasai M, Yoshiga D, Kanba S (2013): Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon‐γ‐stimulated microglia in co‐culture model. Schizophr Res 151:20–28. [DOI] [PubMed] [Google Scholar]
  52. Semple SJ, Zians J, Grant I, Patterson TL (2005): Impulsivity and methamphetamine use. J Subst Abuse Treat 29:85–93. [DOI] [PubMed] [Google Scholar]
  53. Shin YW, Kwon JS, Ha TH, Park HJ, Kim DJ, Hong SB, Moon WJ, Lee JM, Kim IY, Kim SI, Chung EC (2006): Increased water diffusivity in the frontal and temporal cortices of schizophrenic patients. NeuroImage 30:1285–1291. [DOI] [PubMed] [Google Scholar]
  54. Shizukuishi T, Abe O, Aoki S (2013): Diffusion tensor imaging analysis for psychiatric disorders. Magn Reson Med Sci 12:153–159. [DOI] [PubMed] [Google Scholar]
  55. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen‐Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy R, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004): Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23:208–219. [DOI] [PubMed] [Google Scholar]
  56. Smith SM, Jenkinson M, Johansen‐Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TEJ (2006): Tract‐based spatial statistics: Voxelwise analysis of multi‐subject diffusion data. NeuroImage 31:1487–1505. [DOI] [PubMed] [Google Scholar]
  57. Stautz K, Cooper A (2013): Impulsivity‐related personality traits and adolescent alcohol use: A meta‐analytic review. Clin Psychol Rev 33:574–592. [DOI] [PubMed] [Google Scholar]
  58. Sung YH, Cho SC, Hwang J, Kim SJ, Kim H, Bae S, Kim N, Chang KH, Daniels M, Renshaw PF, Lyoo IK (2007): Relationship between N‐acetyl‐aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: A proton magnetic resonance spectroscopy study. Drug Alcohol Depend 88:28–35. [DOI] [PubMed] [Google Scholar]
  59. Takahashi N, Sakurai T, Davis KL, Buxbaum JD (2011): Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol 93:13–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED (2004): Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24:6028–6036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Tobias MC, O'Neill J, Hudkins M, Bartzokis G, Dean AC, London ED (2010): White‐matter abnormalities in brain during early abstinence from methamphetamine abuse. Psychopharmacology 209:13–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Verdejo‐Garcia A, Bechara A, Recknor EC, Perez‐Garcia M (2007): Negative emotion‐driven impulsivity predicts substance dependence problems. Drug Alcohol Depend 91:213–219. [DOI] [PubMed] [Google Scholar]
  63. Wang Q, Cheung C, Deng W, Li M, Huang C, Ma X, Wang Y, Jiang L, Sham PC, Collier DA, Gong Q, Chua SE, McAlonan GM, Li T (2013): White‐matter microstructure in previously drug‐naive patients with schizophrenia after 6 weeks of treatment. Psychol Med 43:2301–2309. [DOI] [PubMed] [Google Scholar]
  64. Wheeler‐Kingshott CA, Cercignani M (2009): About ‘axial’ and ‘radial’ diffusivities. Magn Reson Med 61:1255–1260. [DOI] [PubMed] [Google Scholar]
  65. White T, Nelson M, Lim KO (2008): Diffusion tensor imaging in psychiatric disorders. Top Magn Reson Imaging 19:97–109. [DOI] [PubMed] [Google Scholar]
  66. White T, Ehrlich S, Ho BC, Manoach DS, Caprihan A, Schulz SC, Andreasen NC, Gollub RL, Calhoun VD, Magnotta VA (2013): Spatial characteristics of white matter abnormalities in schizophrenia. Schizophr Bull 39:1077–1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE (2014): Permutation inference for the general linear model. NeuroImage 92:381–397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. World Medical Association (2013): WMA declaration of Helsinki: Ethical principles for medical research involving human subjects. Retrieved from http://www.wma.net/en/30publications/10policies/b3/. [DOI] [PubMed]
  69. Zhang X, Stein EA, Hong LE (2010): Smoking and schizophrenia independently and additively reduce white matter integrity between striatum and frontal cortex. Biol Psychiatry 68:674–677. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Human Brain Mapping are provided here courtesy of Wiley

RESOURCES